Chen Ligong, Salinas Gregory D, Li Xiaohua
Department of Psychiatry and Behavioral Neurobiology, University of Alabama at Birmingham, Birmingham, Alabama, USA.
Mol Pharmacol. 2009 Dec;76(6):1150-61. doi: 10.1124/mol.109.056994. Epub 2009 Sep 9.
In response to 5-hydroxytryptamine (5-HT), the type 1 serotonin receptors (5-HT1Rs) preferentially couple to the inhibitory G protein and elicit many physiological and behavioral processes. However, their regulation by intracellular protein kinases has not been fully investigated. In this study, we identified that glycogen synthase kinase-3 (GSK3) differentially regulates 5-HT1Rs. In receptor-expressing cells and brain slices, activation of both 5-HT1AR and 5-HT1BR reduced forskolin-stimulated cAMP production, but only the effect of 5-HT1BR was abolished by selective GSK3 inhibitors, deletion of GSK3beta by RNAi, or overexpression of impaired GSK3beta mutants (R96A and K85,86A). A consensus GSK3 phosphorylation sequence was identified between the serine-154 and threonine-158 in the second intracellular loop of 5-HT1BR. Mutation of either serine-154 or threonine-158 to alanine significantly reduced response of 5-HT1BR to 5-HT. Active GSK3beta interacted with resting 5-HT1BR to form a protein complex. The interaction was enhanced by receptor activation, abolished by GSK3 inhibitors, and dependent on the phosphorylation state of serine-154. In addition, regulation of 5-HT1BR by GSK3 changed the dynamics of agonist-induced cell surface receptor internalization, in which lack of phosphorylation at Ser154 resulted in sustained reduction of 5-HT1BR at the cell surface. Although the physiological consequences of selective regulation of 5-HT1BR by GSK3 remain to be identified, findings in this study reveal a new function of GSK3 as a protein kinase that is able to selectively regulate G protein-coupled receptors.
对5-羟色胺(5-HT)产生反应时,1型血清素受体(5-HT1Rs)优先与抑制性G蛋白偶联,并引发许多生理和行为过程。然而,细胞内蛋白激酶对它们的调节尚未得到充分研究。在本研究中,我们发现糖原合酶激酶-3(GSK3)对5-HT1Rs有不同的调节作用。在表达受体的细胞和脑片中,5-HT1AR和5-HT1BR的激活均降低了福司可林刺激的环磷酸腺苷(cAMP)生成,但只有5-HT1BR的作用被选择性GSK3抑制剂、RNA干扰介导的GSK3β缺失或受损的GSK3β突变体(R96A和K85,86A)的过表达所消除。在5-HT1BR的第二个细胞内环中,丝氨酸-154和苏氨酸-158之间鉴定出一个共有GSK3磷酸化序列。将丝氨酸-154或苏氨酸-158突变为丙氨酸会显著降低5-HT1BR对5-HT的反应。活性GSK3β与静息状态的5-HT1BR相互作用形成蛋白质复合物。这种相互作用在受体激活时增强,被GSK3抑制剂消除,并依赖于丝氨酸-154的磷酸化状态。此外,GSK3对5-HT1BR的调节改变了激动剂诱导的细胞表面受体内化动力学;其中Ser154处缺乏磷酸化导致5-HT1BR在细胞表面持续减少。尽管GSK3对5-HT1BR选择性调节的生理后果仍有待确定,但本研究结果揭示了GSK3作为一种能够选择性调节G蛋白偶联受体的蛋白激酶的新功能。